OraSure Technologies Inc. (NASDAQ:OSUR) fell 3.4% on Monday . The company traded as low as $6.23 and last traded at $6.24, with a volume of 205,828 shares trading hands. The stock had previously closed at $6.46.

A number of brokerages recently weighed in on OSUR. Raymond James Financial Inc. cut shares of OraSure Technologies from an “outperform” rating to a “market perform” rating and set a $8.00 price objective on the stock. in a research note on Monday, June 13th. Zacks Investment Research cut shares of OraSure Technologies from a “buy” rating to a “hold” rating in a research note on Friday, April 15th. BTIG Research restated a “buy” rating and set a $8.00 price objective on shares of OraSure Technologies in a research note on Tuesday, July 5th. TheStreet cut shares of OraSure Technologies from a “buy” rating to a “hold” rating in a research note on Friday, July 1st. Finally, Mizuho restated an “outperform” rating and set a $8.00 price objective on shares of OraSure Technologies in a research note on Tuesday, July 5th. Three analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. OraSure Technologies presently has an average rating of “Buy” and a consensus price target of $8.08.

The company has a 50 day moving average of $6.92 and a 200 day moving average of $6.71. The firm has a market cap of $357.87 million and a PE ratio of 36.24.

OraSure Technologies (NASDAQ:OSUR) last announced its quarterly earnings results on Wednesday, May 4th. The company reported $0.04 earnings per share for the quarter, beating analysts’ consensus estimates of $0.02 by $0.02. The company earned $29.10 million during the quarter, compared to the consensus estimate of $28.82 million. The company’s revenue for the quarter was up 7.4% compared to the same quarter last year. On average, equities analysts anticipate that OraSure Technologies Inc. will post $0.26 EPS for the current year.

Other hedge funds recently made changes to their positions in the company. Dimensional Fund Advisors LP boosted its stake in shares of OraSure Technologies by 31.0% in the fourth quarter. Dimensional Fund Advisors LP now owns 840,598 shares of the company’s stock worth $5,414,000 after buying an additional 199,049 shares during the period. Morgan Stanley boosted its stake in shares of OraSure Technologies by 40.9% in the fourth quarter. Morgan Stanley now owns 363,707 shares of the company’s stock worth $2,342,000 after buying an additional 105,627 shares during the period. Oxford Asset Management bought a new stake in shares of OraSure Technologies during the fourth quarter worth $1,209,000. Finally, American Century Companies Inc. bought a new stake in shares of OraSure Technologies during the fourth quarter worth $1,371,000.

OraSure Technologies, Inc (OraSure) is involved in the development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices using its technologies, as well as other diagnostic products, including immunoassays and other in vitro diagnostic tests that are used on other specimen types.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.